Connect Biopharma Holdings LtdNASDAQ:CNTB
- LAST PRICE1.3400
- TODAY'S CHANGE (%)-0.0200 (-1.4706%)
- Bid / Lots1.3200/ 1
- Ask / Lots1.3700/ 3
- Open / Previous Close1.3000 / 1.3600
- Day Range
- 52 Week Range
- Volume57,106
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CNTB |
|---|---|---|
| 09:32 ET | 963 | 1.3 |
| 09:57 ET | 2095 | 1.3507 |
| 10:19 ET | 368 | 1.35 |
| 10:39 ET | 320 | 1.3388 |
| 11:02 ET | 100 | 1.3499 |
| 11:04 ET | 1000 | 1.345 |
| 11:06 ET | 7540 | 1.34 |
| 11:11 ET | 100 | 1.362 |
| 11:47 ET | 500 | 1.4 |
| 12:32 ET | 1000 | 1.33 |
| 12:34 ET | 16500 | 1.33 |
| 12:36 ET | 1200 | 1.3669 |
| 12:38 ET | 900 | 1.3608 |
| 12:39 ET | 700 | 1.3715 |
| 12:41 ET | 5300 | 1.37 |
| 12:43 ET | 9300 | 1.36 |
| 12:48 ET | 1000 | 1.3594 |
| 12:56 ET | 100 | 1.37 |
| 02:13 ET | 2048 | 1.3701 |
| 02:24 ET | 500 | 1.3699 |
| 02:47 ET | 2000 | 1.32 |
| 02:54 ET | 1138 | 1.31 |
| 02:58 ET | 200 | 1.34 |
Apr 17, 2024
DJ Connect Biopharma Is Maintained at Buy by HC Wainwright & Co., from 6:50AM ET on Wednesday Apr 17, 2024 by Dow Jones
6:50AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 16, 2024
Press Release: Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday Apr 16, 2024 by Dow Jones
4:05PM ET on Tuesday Apr 16, 2024 by Dow JonesConnect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday Apr 16, 2024 by Dow Jones
4:05PM ET on Tuesday Apr 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Connect Biopharma Holdings Ltd | 74.9M | -1.2x | --- |
Passage Bio Inc | 75.2M | -0.7x | --- |
Cognition Therapeutics Inc | 75.3M | -2.3x | --- |
Athira Pharma Inc | 73.6M | -0.6x | --- |
Tempest Therapeutics Inc | 77.2M | -1.8x | --- |
Corvus Pharmaceuticals Inc | 72.6M | -2.6x | --- |
Company Information
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of T cell-driven inflammatory diseases. The Company’s lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha (IL-4Ra) in development for the treatment of atopic dermatitis and asthma. Its second advanced product candidate, CBP-307, is a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis (UC). The Company’s third product candidate, CBP-174, is a peripherally acting antagonist of histamine receptor 3, in development for the treatment of pruritus associated with atopic dermatitis (AD). It has clinical development activities in the United States, the People’s Republic of China (PRC), Europe, and Australia and operations in those geographies, as well as Hong Kong. Its subsidiaries include Connect Biopharma HongKong Limited, Connect Biopharm LLC and others.
Contact Information
- Headquarters
- 12265 El Camino Real, Suite 350SAN DIEGO, CA, United States 92130
- Phone
- 858-727-1040
- Fax
- ---
Executives
- Chairman of the Board, President, Co-Founder
- Wubin Pan
- Chief Executive Officer, Co-Founder, Director
- Zheng Wei
- Chief Financial Officer
- Steven Chan
- Chief Business Officer
- Selwyn Ho
- Chief Medical Officer
- Chin Lee
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $74.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.08 |
Book Value | $1.76 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
